PIAS1 and breast cancer: IHC analyses indicate that PIAS1 is significantly upregulated in primary breast cancer samples at early stages of breast ductal carcinoma in situ (DCIS) as well as invasive ductal carcinoma (IDC) (Fig. 1a).